Results 111 to 120 of about 8,881 (212)

[Adverse reactions to drugs used for COVID-19 in five Latin American countriesReações adversas a medicamentos utilizados para a COVID-19 em cinco países da América Latina]. [PDF]

Rev Panam Salud Publica, 2022
Orjuela-Rodríguez T, Rojas-Cortés R, Vergara V, Aldunate F, Jiménez G, Orta IA, Serrano K, Jiménez G, Gil González DM, Gutiérrez D, Cortez FB, González JD, Porrás A, Castro JL.   +13 more
europepmc   +1 more source

[Experience of setting up a state pharmacovigilance committee during the COVID-19 pandemicExperiencia de la puesta en marcha de un comité estatal de farmacovigilancia durante la pandemia de COVID-19]. [PDF]

Rev Panam Salud Publica
Mello López A, Sartori AMC, Oliveira SLV, Nunes EM, Nemeth K, Siqueira REB, Lopes MH, Weckx LY, Veiga APR, Silva JME, Salomão MLM, Kurozawa LL, Maruzo A, Haziot MEJ, Penalva de Oliveira AC, Berselli Marinho AKB, Caramelli B, Sato HK, Fernandes EG.   +18 more
europepmc   +1 more source

[Medication Review with Follow-up Service provided by the Community Pharmacy as a care practice for the optimization of pharmacotherapy in patient with urticaria and pruritus]. [PDF]

Farm Comunitarios, 2023
Pérez Rodríguez RO, Barreto Corujo NJ.
europepmc   +1 more source

Signals of disproportionate reporting of events supposedly attributable to COVID-19 vaccines in children and adolescents: case-non-case study, Brazil, 2022. [PDF]

Epidemiol Serv Saude
Silva RMA, Nóbrega MEBD, Percio J, Martins AF, Almeida SLR, Porto VBG.   +5 more
europepmc   +1 more source

[Pharmacovigilance of COVID-19 Vaccines in Brazil: Actions Taken, Lessons Learned, and Next StepsFarmacovigilancia de las vacunas contra la COVID-19 en Brasil: medidas adoptadas, enseñanzas extraídas y próximos pasos]. [PDF]

Rev Panam Salud Publica
Silva RMA, Cabral CM, Percio J, da Nóbrega MEB, Kobayashi CD, Martins AF, Cardoso FD, Porto VBG, Capovilla L, de Moraes MB, Andrade PHS, Fernandes EG.   +11 more
europepmc   +1 more source

Boletín de farmacovigilancia y tecnovigilancia, junio 2017

, 2017
En el presente número se muestra el resultado de la evaluación de los indicadores de farmacovigilancia y de tecnovigilancia del año 2016, un artículo sobre los reportes de sospechas de reacciones adversas asociados a errores de medicación, un artículo sobre reportes de sospecha de reacciones adversas asociados a producto “dietético”, y otro sobre ...
openaire   +1 more source

Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Caffaratti M, Cañás M, Domosbian DE, Giraudo E, González AM, Lorenzo A, Núñez Montoya S, Rocha MT, Traverso ML, Uema S.   +9 more
europepmc   +1 more source

Patterns and persistence of use, effectiveness, safety, clinical inertia, and adherence related to Levothyroxine treatment with real-world evidence. An observational, longitudinal and retrospective study. [PDF]

Endocrine
Valladales-Restrepo LF, Londoño-Cano DA, Muñoz-Velez CM, Soto-Romero LM, Tafur-Ramirez ME, Rojas-Varón MJ, Machado-Alba JE.   +6 more
europepmc   +1 more source

[Bullous pemphigoid associated with dipeptidil peptidase-4 inhibitors]. [PDF]

Aten Primaria, 2023
Garriga Casanovas A.
europepmc   +1 more source

Reacciones adversas medicamentosas por el uso de Midazolam 7.5 mg. I:V: en la realización de legrado endouterino a mujeres de 14 a 35 años ingresadas a la sala de servicio de alto riesgo obstétrico (ARO) en el Hosapital Bertha Calderón. Agosto 2010-Octubre 2010 [PDF]

, 2011
Guevara Téllez, Javier Salvador, Jiménez Valencia, Daniela, Narváez Sotelo, Javier Ariel   +2 more
core